Methods for the Treatment of Leber Congenital Amaurosis
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application PCT/EP2012/060906, filed Jun 8, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,012,425 | Methods for the Treatment of Leber Congenital Amaurosis In force · High confidence UsedRemaining | Université Paris Cité | In force | High confidence | ||
| US 9,487,782 | Methods for the Treatment of Leber Congenital Amaurosis In force · Medium confidence | Université Paris Cité | In force | Medium confidence | ||
| US 9,777,272 | Methods for the Treatment of Leber Congenital Amaurosis In force · Medium confidence | Université Paris Cité | In force | Medium confidence | ||
| US 10,597,654 | Methods for the Treatment of Leber Congenital Amaurosis In force · Medium confidence | Université Paris Cité | In force | Medium confidence | ||
| US 11,492,621 | Methods for the Treatment of Leber Congenital Amaurosis In force · Medium confidence | Université Paris Cité | In force | Medium confidence |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.